Admedus divesting non-core business; to focus on ADAPT product portfolio – Proactive Investors Australia
() has entered into an agreement to sell part of its Infusion business to a subsidiary of BTC Health Ltd () for $6.3 million. This will complete the first phase of the Infusion business divestiture. Completion of the sale is subject to certain conditions being satisfied with the sale expected to complete in…
Details